Clinical trial
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
NCT00086619 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00086619 |
|---|---|
| Title | Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women |
| Official title | Evaluation of Factors That Affect Skeletal Responses to PTH |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postmenopausal Osteoporosis, Osteoporosis |
| Intervention type | Drug |
| Interventions | synthetic hPTH 1-34 |
| Enrollment | 80 |
| Start date | May 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jul 8, 2004 |
| Last update posted | Oct 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: